Article
Comparison between Elecsys HBsAg II and architect HBsAg QT assays for quantification of hepatitis B surface antigen among patients coinfected with HIV and hepatitis B virus.
Clinical and vaccine immunology : CVI - 1 Feb 2012
Maylin Sarah, Boyd Anders, Delaugerre Constance, Zoulim Fabien, Lavocat Fabien, Simon François, Girard Pierre-Marie, Lacombe Karine
Abstract excerpt
Hepatitis B surface antigen (HBsAg) quantification has been steadily gaining interest as a clinical marker of therapeutic efficacy, for which two commercial assays are currently available: Architect HBsAg QT (Architect) and Elecsys HBsAg II (Elecsys). HBsAg quantification was evaluated using both assays in 126 human immunodeficiency virus (HIV) and hepatitis B virus (HBV)-coinfected patients initiating treatment...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.